Company Search:
Advanced Search
Sponsored Links
Zoetis Inc Company Snapshot
Zoetis Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Zoetis Inc with three other companies in this sector in the United States: Regeneron Pharmaceuticals Incorporated (2016 sales of $4.86 billion of which 100% was Research & Development), Endo International PLC ($4.01 billion of which 64% was Generics), and Eisai Company Limited ($4.56 billion of which 49% was Pharmaceutical Business -Japan).

Sales Analysis. During the year ended December of 2016, sales at Zoetis Inc were $4.89 billion. This is an increase of 2.6% versus 2015, when the company's sales were $4.77 billion. Sales of International saw an increase of 0.2% in 2016, from $2.39 billion to $2.39 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Zoetis Inc
  Stock Performance Chart for Zoetis Inc
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): 54.00
(Figures in U.S. Dollars)
1 Week 1.2%   13 Weeks 2.8%  
4 Weeks 2.9%   52 Weeks 32.2%  
Zoetis Inc Key Data:
  Ticker: ZTS Country: United States
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 4,888,000,000
(Year Ending Jan 2017).
Employees: 9,000
  Currency: U.S. Dollars Market Cap: 26,614,186,038
  Fiscal Yr Ends: December Shares Outstanding: 492,855,297
  Share Type: Class A Common Closely Held Shares: 174,642
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.